CeGaT has established a straightforward re-evaluation process: For two years after the medical report got issued, we will regularly review the current scientific status of the VUS reported for your patients. If new information lead to a better understanding and reclassification of the variant to “benign”, “likely benign”, “likely pathogenic”, or “pathogenic”, we proactively report them to you. If desired, we reanalyze and reinterpret the test results for the variant based on the new findings and issue an updated medical report.
After the initial period, you can request once a year information about the status of your patient’s VUS for further three years.
The VUS re-evaluation is free of charge. It is carried out as a standard for all test results from Single Gene Testing, Panel Diagnostics, and Exome Diagnostics issued after October 1, 2019. If you wish a re-evaluation of medical reports generated before October 1, 2019, please contact our sales team (email@example.com).